MeSH tree: C17.800.859.675
A technological platform developed by Brazilian researchers could revolutionize the treatment of skin diseases such as psoriasis and vitiligo. The group, affiliated with the NanoGeneSkin laboratory at the University of São ...
Jun 8, 2026
0
7
Three-quarters of people who respond well to the newest types of biologics for psoriasis can safely reduce their dosage, often even by half. These medications then work just as effectively, according to a study led by Radboud ...
Jun 1, 2026
0
7
A text-messaging intervention can improve patient activation and cardiovascular risk behaviors in adults with psoriasis, according to a study published online May 13 in JAMA Dermatology.
May 19, 2026
0
3
Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from Queen Mary University of London's Precision Healthcare University Research Institute and Berlin Institute of Health (BIH) ...
May 6, 2026
0
4
New research has shown that single blood vessel cells that appear in the earliest stages of lab-grown skin organoids have the ability to form complex microvascular networks that grow and mature over time. These self-organizing ...
Apr 28, 2026
0
4
A predictive model for psoriasis relapse risk demonstrates moderate performance, according to a study published online April 11 in Scientific Reports.
Apr 28, 2026
0
4
Arthritis includes a range of conditions that affect the joints, from inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis to more common conditions like osteoarthritis. Many people experience pain, ...
Apr 16, 2026
0
13
Scientists investigating the naturally occurring immunopeptide PEPITEM have shown reductions in arthritic joint swelling to a degree comparable to the current standard of care, and reduce the inflammatory changes that cause ...
Apr 13, 2026
0
21
For patients undergoing total hip arthroplasty (THA), those with cutaneous psoriasis (PsC) and psoriatic arthritis (PsA) have an increased risk for complications, according to a study published online March 22 in the Journal ...
Mar 31, 2026
0
2
The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
Mar 11, 2026
0
7
